L. Ferrari

机构：Fundación para la Investigación, Docencia y Prevención del Cáncer, Fondazione IRCCS Istituto Nazionale dei Tumori · ORCID：0000-0001-5364-5396

发表论文 141 篇 · 总被引 3457 次 · h-index 29

代表论文

• Italian cancer figures, report 2012: Cancer in children and adolescents. (2013 · BOA (University of Milano-Bicocca) · 被引 118)
• Accuracy of point of care ultrasound to identify the source of infection in septic patients: a prospective study (2016 · Internal and Emergency Medicine · 被引 60)
• Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy (2014 · Epidemiologia e prevenzione · 被引 39)
• Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor‐positive, advanced breast cancer: A real‐world experience (2018 · Journal of Cellular Physiology · 被引 27)
• Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study (2017 · The Breast · 被引 23)
• COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT study (2020 · ESMO Open · 被引 18)